These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26122637)

  • 21. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D; Aktas O; Hartung HP; Küry P
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?
    Akkermann R; Jadasz JJ; Azim K; Küry P
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.
    Aktas O; Kieseier B; Hartung HP
    Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
    Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
    Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection and neuroregeneration in multiple sclerosis.
    Stangel M
    J Neurol; 2008 Dec; 255 Suppl 6():77-81. PubMed ID: 19300964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].
    Kleinschnitz C; Meuth SG; Kieseier BC; Wiendl H
    Nervenarzt; 2007 Aug; 78(8):883-911. PubMed ID: 17551708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olesoxime accelerates myelination and promotes repair in models of demyelination.
    Magalon K; Zimmer C; Cayre M; Khaldi J; Bourbon C; Robles I; Tardif G; Viola A; Pruss RM; Bordet T; Durbec P
    Ann Neurol; 2012 Feb; 71(2):213-26. PubMed ID: 22367994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ; Aigner L; Rivera FJ; Küry P
    Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remyelination in multiple sclerosis: a new role for neurotrophins?
    Althaus HH
    Prog Brain Res; 2004; 146():415-32. PubMed ID: 14699977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection in multiple sclerosis.
    Karussis D; Grigoriadis S; Polyzoidou E; Grigoriadis N; Slavin S; Abramsky O
    Clin Neurol Neurosurg; 2006 Mar; 108(3):250-4. PubMed ID: 16413962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotection and repair in multiple sclerosis.
    Franklin RJ; ffrench-Constant C; Edgar JM; Smith KJ
    Nat Rev Neurol; 2012 Nov; 8(11):624-34. PubMed ID: 23026979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation.
    Roggeri A; Schepers M; Tiane A; Rombaut B; van Veggel L; Hellings N; Prickaerts J; Pittaluga A; Vanmierlo T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
    Stankoff B; Jadasz JJ; Hartung HP; Küry P; Zalc B; Lubetzki C
    Curr Opin Neurol; 2016 Jun; 29(3):286-92. PubMed ID: 27035897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a central nervous system axonal myelination assay for high throughput screening.
    Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
    BMC Neurosci; 2016 Apr; 17():16. PubMed ID: 27103572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of oligodendrocyte precursor cells by low doses of HSP90 inhibitors in cell culture.
    Cid C; Alcazar A
    Exp Neurol; 2010 Sep; 225(1):29-33. PubMed ID: 19948165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination.
    Marchionni MA; Cannella B; Hoban C; Gao YL; Garcia-Arenas R; Lawson D; Happel E; Noel F; Tofilon P; Gwynne D; Raine CS
    Adv Exp Med Biol; 1999; 468():283-95. PubMed ID: 10635037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.